drugset / Trial / NCT02539706

Menstrual Cycle on Injection Pain of Rocuronium

NCT02539706

Completed 100 enrolled Aydin Adnan Menderes University
RandomizedParallel-groupQuadruple-blindDiagnostic

Summary

This study evaluates the effects of rocuronium injection pain to menstrual cycle phases.Half of participants will receive follicular phase, while the other half will receive luteal phase.

Timeline

Start
2014-01-06
Primary completion
2015-09-06
Completion
2015-10-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rocuronium Other / unclassified 0.6 mg/kg Intravenous

Indications